Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Long Term Debt 2016–2025
Amneal Pharmaceuticals Inc. annual long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Amneal Pharmaceuticals Inc. long term debt as of December 31, 2025: 2.57B, a 7.79% increase year-over-year.
- Amneal Pharmaceuticals Inc. long term debt for 2025 were 2.57B, a 7.79% increase from 2024.
- Amneal Pharmaceuticals Inc. long term debt for 2024 were 2.39B, a 1.41% decrease from 2023.
- Amneal Pharmaceuticals Inc. long term debt for 2023 were 2.42B, a 7.70% decrease from 2022.
- Amneal Pharmaceuticals Inc. long term debt for 2022 were 2.62B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amneal Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $2,572 |
| 2024 | $2,386 |
| 2023 | $2,420 |
| 2022 | $2,622 |
| 2021 | $2,711 |
| 2020 | $2,779 |
| 2019 | $2,631 |
| 2018 | $2,652 |
| 2017 | $1,444 |
Amneal Pharmaceuticals Inc. Long Term Debt — FAQ
Amneal Pharmaceuticals Inc. (AMRX) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMRX's long term debt history?
The chart and table above show Amneal Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.